Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,389 | 2,142 | 1,279 | 1,983 | 3,375 |
| Receivables | N/A | N/A | N/A | 30 | 46 |
| Other current assets | 0 | 0 | 99 | 2 | 2 |
| TOTAL | $7,500 | $2,337 | $1,453 | $2,111 | $3,508 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 2 | 2 | 1 |
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| TOTAL | $2,040 | $2,040 | $2,041 | $2,041 | $2,040 |
| Total Assets | $9,539 | $4,377 | $3,494 | $4,152 | $5,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 486 | 502 | 268 | 444 | 585 |
| TOTAL | $486 | $502 | $269 | $444 | $585 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $486 | $502 | $269 | $444 | $585 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58 | N/A | 17 | 13 | 13 |
| Common Shares | 15 | 5 | 4 | 3 | 3 |
| Retained earnings | -10,900 | -9,466 | -8,438 | -7,487 | -6,117 |
| Other shareholders' equity | 48 | 64 | 51 | 16 | 7 |
| TOTAL | $9,054 | $3,875 | $3,225 | $3,708 | $4,963 |
| Total Liabilities And Equity | $9,539 | $4,377 | $3,494 | $4,152 | $5,548 |